Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Blog
Biosimilars Council Press Releases
Blog
Blog
July 30, 2019
AAM
A Generic Summer Savings Tour: How Did Your State Do?
Blog
July 29, 2019
AAM
Prescription Drug Safety on Campus
Blog
July 11, 2019
AAM
The House Has Spoken – It’s Time to Fix USMCA’s Pharmaceutical Provisions
Blog
June 26, 2019
AAM
GRx+Biosims 2019: Register Now and Be Part of the Solution
Blog
June 25, 2019
AAM
Section 205 is Still Flawed and Erodes the Only Incentive to Challenge Brand-Name Drug Patents. Here’s Why.
Blog
June 19, 2019
AAM
Congress: Don’t Punish American Patients
Blog
May 29, 2019
AAM
Five Lessons from a National Collaboration to Promote Prescription Drug Safety
Blog
May 28, 2019
AAM
Join AAM Today!
Blog
May 23, 2019
AAM
WiHP Event Features Congressional Speaker
Blog
May 13, 2019
AAM
Highlights from the NAFTA 2.0 Congressional Briefing: The May 10 Amendments
Blog
May 1, 2019
AAM
Jonnie Is Informed about Generic Prescriptions. How Does Your Knowledge Measure Up?
Blog
April 30, 2019
AAM
AAM Wins Bronze Award from Association TRENDS
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
